AIMS: To investigate the role of medication in 20-year trends in blood pressure (BP) and blood lipids in older British men. METHODS AND RESULTS: BP and lipids were measured in 4231 men from a representative cohort at baseline (1978-1980, aged 40-59 years) and after 20 years (1998-2000). Cohort-wide age-adjusted 20-year mean changes were as follows: systolic BP -7.6 mmHg (95% confidence interval: -9.7 to -5.4); diastolic BP +3.3 mmHg (+2.2 to +4.5); non-high-density lipoprotein (HDL)-cholesterol -0.4 mmol/l (-0.5 to -0.2); HDL-cholesterol +0.16 mmol/l (+0.13 to +0.19). Much (79%) of the systolic BP fall occurred only among 1561 men (37%) reporting the use of BP-lowering medication during the follow-up; systolic BP changed by -12.3 mmHg (-14.7 to -9.9) and -1.6 mmHg (-3.7 to +0.5) among medication users and men not using medication, respectively (P<0.001 for medication-time interaction). One-third of the non-HDL-cholesterol fall occurred only among 302 men (8%) reporting the use of lipid-regulating drugs; non-HDL-cholesterol changed by -1.8 mmol/l (-2.0 to -1.6) and -0.2 mmol/l (-0.4 to -0.1) among medication users and men not using medication, respectively (P<0.001 for interaction). The HDL-cholesterol increase was not associated with lipid-regulating drug use (P=0.15 for interaction). CONCLUSION: Decreases in BP were largely confined to medication users and overall changes in non-HDL-cholesterol were modest, suggesting the need for greater efforts to reduce BP and cholesterol among the general population. HDL-cholesterol increased among all men, likely reflecting cohort-wide improvements in associated health behaviours.
AIMS: To investigate the role of medication in 20-year trends in blood pressure (BP) and blood lipids in older British men. METHODS AND RESULTS: BP and lipids were measured in 4231 men from a representative cohort at baseline (1978-1980, aged 40-59 years) and after 20 years (1998-2000). Cohort-wide age-adjusted 20-year mean changes were as follows: systolic BP -7.6 mmHg (95% confidence interval: -9.7 to -5.4); diastolic BP +3.3 mmHg (+2.2 to +4.5); non-high-density lipoprotein (HDL)-cholesterol -0.4 mmol/l (-0.5 to -0.2); HDL-cholesterol +0.16 mmol/l (+0.13 to +0.19). Much (79%) of the systolic BP fall occurred only among 1561 men (37%) reporting the use of BP-lowering medication during the follow-up; systolic BP changed by -12.3 mmHg (-14.7 to -9.9) and -1.6 mmHg (-3.7 to +0.5) among medication users and men not using medication, respectively (P<0.001 for medication-time interaction). One-third of the non-HDL-cholesterol fall occurred only among 302 men (8%) reporting the use of lipid-regulating drugs; non-HDL-cholesterol changed by -1.8 mmol/l (-2.0 to -1.6) and -0.2 mmol/l (-0.4 to -0.1) among medication users and men not using medication, respectively (P<0.001 for interaction). The HDL-cholesterol increase was not associated with lipid-regulating drug use (P=0.15 for interaction). CONCLUSION: Decreases in BP were largely confined to medication users and overall changes in non-HDL-cholesterol were modest, suggesting the need for greater efforts to reduce BP and cholesterol among the general population. HDL-cholesterol increased among all men, likely reflecting cohort-wide improvements in associated health behaviours.
Authors: Guy De Backer; Ettore Ambrosioni; Knut Borch-Johnsen; Carlos Brotons; Renata Cifkova; Jean Dallongeville; Shah Ebrahim; Ole Faergeman; Ian Graham; Giuseppe Mancia; Volkert Manger Cats; Kristina Orth-Gomér; Joep Perk; Kalevi Pyörälä; José L Rodicio; Susana Sans; Vedat Sansoy; Udo Sechtem; Sigmund Silber; Troels Thomsen; David Wood Journal: Eur J Cardiovasc Prev Rehabil Date: 2003-08
Authors: F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin Journal: N Engl J Med Date: 2001-01-04 Impact factor: 91.245
Authors: Majid Ezzati; Ziad Obermeyer; Ioanna Tzoulaki; Bongani M Mayosi; Paul Elliott; David A Leon Journal: Nat Rev Cardiol Date: 2015-06-16 Impact factor: 32.419
Authors: Sheena E Ramsay; Peter H Whincup; Sarah L Hardoon; Lucy T Lennon; Richard W Morris; S G Wannamethee Journal: PLoS One Date: 2011-05-13 Impact factor: 3.240
Authors: Sarah L Hardoon; Richard W Morris; Peter H Whincup; Martin J Shipley; Annie R Britton; Gabriel Masset; Silvia Stringhini; Séverine Sabia; Mika Kivimaki; Archana Singh-Manoux; Eric J Brunner Journal: Eur Heart J Date: 2011-06-08 Impact factor: 29.983
Authors: Simone P Rauh; Femke Rutters; Amber A W A van der Heijden; Thomas Luimes; Marjan Alssema; Martijn W Heymans; Dianna J Magliano; Jonathan E Shaw; Joline W Beulens; Jacqueline M Dekker Journal: J Gen Intern Med Date: 2017-12-04 Impact factor: 5.128